Provided by Tiger Trade Technology Pte. Ltd.

ZYMEWORKS INC (US)

28.67
+2.107.90%
Post-market: 28.940.2700+0.94%19:40 EDT
Volume:836.38K
Turnover:23.54M
Market Cap:2.03B
PE:-14.19
High:28.74
Open:26.97
Low:26.77
Close:26.57
52wk High:29.75
52wk Low:13.60
Shares:70.96M
Float Shares:66.05M
Volume Ratio:1.51
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0200
EPS(LYR):-1.0800
ROE:-72.31%
ROA:-24.14%
PB:25.31
PE(LYR):-26.55

Loading ...

Zymeworks Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 06

Stock Track | Zymeworks Soars 5.45% Intraday on Positive Analyst Ratings and Price Target Increases

Stock Track
·
Mar 04

Zymeworks Is Maintained at Outperform by Leerink Partners

Dow Jones
·
Mar 04

Truist Financial Keeps Their Buy Rating on Zymeworks (ZYME)

TIPRANKS
·
Mar 03

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Veeva Systems (VEEV), Zymeworks (ZYME) and Senseonics Holdings (SENS)

TIPRANKS
·
Mar 03

Stifel Nicolaus Reaffirms Their Buy Rating on Zymeworks (ZYME)

TIPRANKS
·
Mar 03

Zymeworks’ Growth Clouded by High Clinical Failure Risk and Regulatory Uncertainty

TIPRANKS
·
Mar 03

Zymeworks Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 02

Zymeworks Publishes Corporate Presentation on Royalty-Driven Growth Strategy and Oncology Pipeline Progress

Reuters
·
Mar 02

Zymeworks Q4 Net Loss Widens, Revenue Falls; Enters $250 Million Financing Agreement with Royalty Pharma

MT Newswires Live
·
Mar 02

Zymeworks, Royalty Pharma enter $250M royalty-backed note financing

TIPRANKS
·
Mar 02

Earnings Flash (ZYME) Zymeworks Posts Q4 Revenue $2.5M, vs. FactSet Est of $19.2M

MT Newswires Live
·
Mar 02

Zymeworks reports Q4 EPS (55c) vs. (31c) last year

TIPRANKS
·
Mar 02

Earnings Flash (ZYME) Zymeworks Posts Q4 Net Loss $0.55 a Share, vs. FactSet Est of $0.46 Loss

MT Newswires Live
·
Mar 02

Canada's Zymeworks 2025 revenue rises 39%

Reuters
·
Mar 02

Zymeworks Q4 2025 EPS $(0.55) Misses $(0.42) Estimate, Sales $2.515M Miss $13.576M Estimate

Benzinga Earnings
·
Mar 02

Zymeworks and Royalty Pharma Enter Into $250 Million Royalty-Backed Note Financing

THOMSON REUTERS
·
Mar 02

Zymeworks Inc - Co to Retain 70% of Ziihera Royalties

THOMSON REUTERS
·
Mar 02

Zymeworks Secures $250 Million Royalty-Backed Note Financing From Royalty Pharma

Reuters
·
Mar 02

Zymeworks FY 2025 revenue rises 39% to USD 106.0 million

Reuters
·
Mar 02